• About us
    • About ImaBiotech
    • Our team
    • Quality Engagement
    • Careers
    • Contact Imabiotech
  • Innovative platforms
    • Overview of Technologies
    • Mass Spectrometry Imaging
    • Laser Microdissection
    • Multimaging™ Software
    • Spatially Resolved Gene Expression
    • High Multiplexing Proteins & Cell Markers
    • Testing Panels
  • Therapeutic areas
    • Oncology
    • Dermatology
    • Ophthalmology
    • Respiratory diseases
    • Central Nervous System
    • Metabolic Disorders
  • Services
    • Overview of Services
    • Biodistribution
    • Biomarkers Discovery
    • Formulation Screening
    • Digital Pathology Services
    • Drug Delivery
    • PK/PD-Pharmacology
    • Safety support
    • Translational Research
    • Clinical Drug Efficacy
  • Resources
    • Conferences and Webinars
    • Articles and research
    • Press releases & In the Press
    • Imabiotech news

Result(s): all

  • Jonathan-stauber-imabiotech-USA

    Press: Lille : ImaBiotech s’installe à Boston, Silicon valley de la médecine

  • News-ImaBiotech-MSI

    Press release: Galderma and ImaBiotech develop a long-term alliance to access Multimaging™ services

  • In-the-press-Imabiotech

    Article: Galderma and ImaBiotech develop a long-term alliance to access Multimaging™ services

  • News-ImaBiotech-MSI

    Quantinetix is specially designed to quantify and normalize MS images in various study types:

  • News-ImaBiotech-MSI

    Quantitation by MS imaging: needs and challenges in pharmaceuticals

« Previous page 1 2 3 4 … 36 Next page »

Search news




© ImaBiotech 2018-2022

Build Your Pathway